Capital Fund Management (CFM)’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,772
Closed -$1.79M 1703
2022
Q4
$1.79M Buy
+29,772
New +$1.74M 0.01% 979
2022
Q3
Sell
-137,496
Closed -$3.73M 1600
2022
Q2
$3.73M Buy
137,496
+17,103
+14% +$500K 0.03% 600
2022
Q1
$4.4M Buy
120,393
+68,330
+131% +$2.46M 0.04% 625
2021
Q4
$2.57M Buy
+52,063
New +$2.89M 0.02% 927
2019
Q4
Sell
-47,000
Closed -$368K 1989
2019
Q3
$368K Buy
47,000
+1,500
+3% +$13.3K ﹤0.01% 1352
2019
Q2
$481K Buy
+45,500
New +$467K ﹤0.01% 1230
2018
Q1
Sell
-8,800
Closed -$330K 2114
2017
Q4
$330K Buy
+8,800
New +$448K ﹤0.01% 1591
2017
Q1
Sell
-6,800
Closed -$334K 1754
2016
Q4
$334K Buy
+6,800
New +$375K ﹤0.01% 1405
2015
Q1
Sell
-15,400
Closed -$320K 1667
2014
Q4
$320K Buy
+15,400
New +$321K ﹤0.01% 1309
2014
Q3
Sell
-26,300
Closed -$593K 1766
2014
Q2
$593K Buy
+26,300
New +$658K 0.01% 1148

Other funds holding PRTA

Capital Fund Management (CFM)'s PRTA Position: Q1 2023 in Review

Capital Fund Management (CFM) sold out of Prothena Corp (PRTA) in Q1 2023, closing a stake of 29,772 shares — an estimated $1.79M sold.

Capital Fund Management (CFM) first reported a position in PRTA in Q2 2014 and held it in 10 quarters. The position peaked at $4.4M in Q1 2022. 191 funds tracked by Wall St. Rank hold PRTA as of Q1 2023.

  • Capital Fund Management (CFM) reported no remaining Prothena Corp position as of Q1 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 29,772 Prothena Corp shares in Q1 2023, an estimated $1.79M.
  • Capital Fund Management (CFM) first reported a position in Prothena Corp in Q2 2014 and held it in 10 quarters.
  • Capital Fund Management (CFM)'s Prothena Corp position peaked at $4.4M in Q1 2022.
  • 191 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2023, filed 15 May 2023.